ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global Reach
JENA, Germany, March 27, 2025 /PRNewswire/ -- ZEISS Medical Technology announced today…
HUTCHMED Announces NMPA Full Approval for ORPATHYS(savolitinib) in China for Patients with Locally Advanced or Metastatic MET Exon 14 NSCLC
January 13, 2025 23:00 ET | Source: HUTCHMED (China) Limited — Indication…
